In the present study, TD pretreatment also suppressed the increases of TNF-α, IL-6, and IL-10 serum levels that occur after hepatic I/R, suggesting that modulation of the inflammatory response could be another mechanism of TD liver protection. This evidence concerns the gene IL6 and thanatophoric dysplasia.